Nifty

:

18652.20

Sensex

:

62957.27

53.55 (0.29%)
110.89 (0.18%)

Login

Nifty
Sensex

:
:

18652.20
62957.27

53.55 (0.29%)
110.89 (0.18%)

Morepen Laboratories Ltd.

Pharmaceuticals & Drugs - API

Rating :

37/99

BSE: 500288 | NSE: MOREPENLAB

Watchlist

NSE BSE

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,300.92
33.64
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,273.52
N/A
1.73

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

16.85
20.59
21.94

EBITDA CAGR (%)

10 Years
5 Years
3 Years

16.01
16.12
14.81

PAT CAGR (%)

10 Years
5 Years
3 Years

-
28.00
44.67

P:E (Median)

8 Years
5 Years
3 Years

31.39
24.14
22.53

P:BV (Average)

8 Years
5 Years
3 Years

4.46
3.74
3.84

EV:EBITDA (Average)

8 Years
5 Years
3 Years

15.73
13.88
14.94

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 23 Mar 22 Var% Dec 22 Dec 21 Var% Sep 22 Sep 21 Var% Jun 22 Jun 21 Var%
Net Sales 336.52 342.44 -1.73% 344.62 372.21 -7.41% 383.34 369.39 3.78% 274.40 365.23 -24.87%
Expenses 321.39 323.26 -0.58% 323.17 341.72 -5.43% 356.26 332.56 7.13% 260.79 322.59 -19.16%
EBITDA 15.13 19.18 -21.12% 21.45 30.49 -29.65% 27.08 36.83 -26.47% 13.61 42.64 -68.08%
EBIDTM 4.50% 5.60% 6.22% 8.19% 7.07% 9.97% 4.96% 11.68%
Other Income 2.99 3.11 -3.86% 1.19 2.69 -55.76% 0.87 11.97 -92.73% 0.71 1.58 -55.06%
Interest 0.56 0.80 -30.00% 0.55 0.75 -26.67% 0.47 0.00 0 0.40 0.21 90.48%
Depreciation 4.61 4.82 -4.36% 4.56 5.28 -13.64% 4.46 5.70 -21.75% 4.37 5.40 -19.07%
PBT 12.94 16.67 -22.38% 17.53 27.15 -35.43% 23.02 43.10 -46.59% 9.55 38.62 -75.27%
Tax 2.67 2.40 11.25% 4.96 5.64 -12.06% 6.50 8.67 -25.03% 2.68 7.77 -65.51%
PAT 10.28 14.27 -27.96% 12.57 21.51 -41.56% 16.52 34.43 -52.02% 6.88 30.85 -77.70%
PATM 3.05% 4.17% 3.65% 5.78% 4.31% 9.32% 2.51% 8.45%
EPS 0.20 0.28 -28.57% 0.25 0.42 -40.48% 0.32 0.67 -52.24% 0.13 0.60 -78.33%

Description Mar 23 Mar 22 Var% Dec 22 Dec 21 Var% Sep 22 Sep 21 Var% Jun 22 Jun 21 Var%
Net Sales 363.69 368.28 -1.25% 348.47 396.50 -12.11% 402.98 395.31 1.94% 302.40 386.73 -21.81%
Expenses 348.13 349.61 -0.42% 327.94 364.38 -10.00% 374.07 353.29 5.88% 287.86 342.88 -16.05%
EBITDA 15.56 18.67 -16.66% 20.52 32.12 -36.11% 28.91 42.03 -31.22% 14.55 43.85 -66.82%
EBIDTM 4.28% 5.07% 5.89% 8.10% 7.17% 10.63% 4.81% 11.34%
Other Income 3.12 3.18 -1.89% 1.22 2.69 -54.65% 0.87 11.97 -92.73% 0.91 1.58 -42.41%
Interest 0.56 0.80 -30.00% 0.55 0.75 -26.67% 0.47 0.00 0 0.40 0.21 90.48%
Depreciation 6.98 6.88 1.45% 7.19 6.93 3.75% 7.00 7.14 -1.96% 6.76 6.69 1.05%
PBT 11.14 14.17 -21.38% 14.00 27.14 -48.42% 22.31 46.86 -52.39% 8.31 38.53 -78.43%
Tax 2.90 1.85 56.76% 5.01 5.62 -10.85% 6.50 9.50 -31.58% 2.68 8.06 -66.75%
PAT 8.24 12.32 -33.12% 8.99 21.52 -58.22% 15.81 37.36 -57.68% 5.63 30.47 -81.52%
PATM 2.27% 3.35% 2.58% 5.43% 3.92% 9.45% 1.86% 7.88%
EPS 0.16 0.26 -38.46% 0.18 0.48 -62.50% 0.31 0.83 -62.65% 0.11 0.68 -83.82%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 1,338.88 1,449.27 1,112.42 791.99 717.24 560.83 547.51 452.46 370.26 335.97 303.35 Net Sales Growth -7.62% 30.28% 40.46% 10.42% 27.89% 2.43% 21.01% 22.20% 10.21% 10.75% Cost Of Goods Sold 903.02 921.58 691.36 487.87 448.98 335.30 328.24 273.04 223.63 194.39 185.79 Gross Profit 435.86 527.68 421.06 304.13 268.26 225.52 219.27 179.42 146.64 141.58 117.56 GP Margin 32.55% 36.41% 37.85% 38.40% 37.40% 40.21% 40.05% 39.65% 39.60% 42.14% 38.75% Total Expenditure 1,261.61 1,320.13 1,000.05 727.52 652.22 500.56 487.02 388.26 323.68 290.16 274.37 Power & Fuel Cost - 18.93 13.00 12.56 13.18 11.08 9.84 7.64 7.41 8.42 8.96 % Of Sales - 1.31% 1.17% 1.59% 1.84% 1.98% 1.80% 1.69% 2.00% 2.51% 2.95% Employee Cost - 150.00 123.20 98.07 84.74 68.22 60.79 51.67 43.52 39.16 34.47 % Of Sales - 10.35% 11.07% 12.38% 11.81% 12.16% 11.10% 11.42% 11.75% 11.66% 11.36% Manufacturing Exp. - 98.96 66.82 48.90 31.27 16.21 15.05 13.33 12.63 12.23 11.33 % Of Sales - 6.83% 6.01% 6.17% 4.36% 2.89% 2.75% 2.95% 3.41% 3.64% 3.73% General & Admin Exp. - 35.93 29.69 31.93 31.21 24.35 21.53 15.34 13.77 14.60 11.43 % Of Sales - 2.48% 2.67% 4.03% 4.35% 4.34% 3.93% 3.39% 3.72% 4.35% 3.77% Selling & Distn. Exp. - 44.90 44.09 35.75 31.72 29.13 29.04 19.87 16.06 15.11 15.48 % Of Sales - 3.10% 3.96% 4.51% 4.42% 5.19% 5.30% 4.39% 4.34% 4.50% 5.10% Miscellaneous Exp. - 49.84 31.89 12.45 11.11 16.26 22.53 7.38 6.66 6.25 15.48 % Of Sales - 3.44% 2.87% 1.57% 1.55% 2.90% 4.11% 1.63% 1.80% 1.86% 2.28% EBITDA 77.27 129.14 112.37 64.47 65.02 60.27 60.49 64.20 46.58 45.81 28.98 EBITDA Margin 5.77% 8.91% 10.10% 8.14% 9.07% 10.75% 11.05% 14.19% 12.58% 13.64% 9.55% Other Income 5.76 20.03 11.77 9.42 3.67 3.54 3.72 1.17 1.36 0.79 2.62 Interest 1.98 2.43 1.79 1.97 2.07 4.29 7.47 10.41 8.63 9.89 11.61 Depreciation 18.00 21.19 28.11 34.43 38.01 33.40 33.56 34.92 38.59 45.77 45.74 PBT 63.04 125.54 94.25 37.48 28.61 26.12 23.17 20.04 0.72 -9.06 -25.75 Tax 16.81 24.48 0.00 5.15 0.00 0.00 0.00 -0.14 0.14 0.00 0.00 Tax Rate 26.67% 19.50% 0.00% 13.74% 0.00% 0.00% 0.00% -0.90% 19.44% 0.00% 0.00% PAT 46.25 101.06 94.25 32.33 28.61 26.12 23.17 15.78 0.58 -6.16 -22.67 PAT before Minority Interest 46.25 101.06 94.25 32.33 28.61 26.12 23.17 15.78 0.58 -6.16 -22.67 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 3.45% 6.97% 8.47% 4.08% 3.99% 4.66% 4.23% 3.49% 0.16% -1.83% -7.47% PAT Growth -54.24% 7.23% 191.52% 13.00% 9.53% 12.73% 46.83% 2,620.69% - - EPS 0.90 1.98 1.84 0.63 0.56 0.51 0.45 0.31 0.01 -0.12 -0.44

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 1,417.54 1,546.83 1,188.06 853.07 768.54 606.51 595.47 485.08 400.64 366.85 325.92 Net Sales Growth -8.36% 30.20% 39.27% 11.00% 26.72% 1.85% 22.76% 21.08% 9.21% 12.56% Cost Of Goods Sold 955.75 980.35 735.29 524.19 479.12 361.28 358.35 293.33 238.62 209.04 193.53 Gross Profit 461.79 566.47 452.77 328.87 289.42 245.23 237.12 191.76 162.02 157.81 132.39 GP Margin 32.58% 36.62% 38.11% 38.55% 37.66% 40.43% 39.82% 39.53% 40.44% 43.02% 40.62% Total Expenditure 1,338.00 1,410.15 1,069.54 784.55 701.02 541.78 534.09 423.52 352.41 317.95 294.97 Power & Fuel Cost - 18.93 13.00 12.56 13.18 11.08 9.84 7.64 7.41 8.42 8.96 % Of Sales - 1.22% 1.09% 1.47% 1.71% 1.83% 1.65% 1.57% 1.85% 2.30% 2.75% Employee Cost - 164.25 135.59 109.91 95.36 76.53 69.69 58.29 48.79 45.08 39.17 % Of Sales - 10.62% 11.41% 12.88% 12.41% 12.62% 11.70% 12.02% 12.18% 12.29% 12.02% Manufacturing Exp. - 98.99 67.21 48.92 31.28 16.21 22.36 13.33 12.68 12.23 11.33 % Of Sales - 6.40% 5.66% 5.73% 4.07% 2.67% 3.76% 2.75% 3.16% 3.33% 3.48% General & Admin Exp. - 42.38 34.71 36.47 36.14 28.52 18.11 18.14 15.89 16.62 13.86 % Of Sales - 2.74% 2.92% 4.28% 4.70% 4.70% 3.04% 3.74% 3.97% 4.53% 4.25% Selling & Distn. Exp. - 53.58 49.66 40.11 32.73 30.04 25.79 23.45 21.40 19.55 20.40 % Of Sales - 3.46% 4.18% 4.70% 4.26% 4.95% 4.33% 4.83% 5.34% 5.33% 6.26% Miscellaneous Exp. - 51.67 34.08 12.39 13.20 18.11 29.95 9.35 7.61 7.01 20.40 % Of Sales - 3.34% 2.87% 1.45% 1.72% 2.99% 5.03% 1.93% 1.90% 1.91% 2.37% EBITDA 79.54 136.68 118.52 68.52 67.52 64.73 61.38 61.56 48.23 48.90 30.95 EBITDA Margin 5.61% 8.84% 9.98% 8.03% 8.79% 10.67% 10.31% 12.69% 12.04% 13.33% 9.50% Other Income 6.12 20.10 12.07 9.48 3.67 3.72 3.72 1.20 1.37 1.22 2.87 Interest 1.98 2.43 1.79 1.98 2.11 4.36 7.56 10.50 8.66 9.92 11.63 Depreciation 27.93 27.64 30.28 36.91 39.90 34.32 33.90 35.20 38.67 45.84 45.80 PBT 55.76 126.70 98.51 39.11 29.18 29.77 23.63 17.06 2.28 -5.64 -23.61 Tax 17.09 25.02 1.42 5.53 0.34 0.00 0.00 -0.13 0.14 0.01 -0.01 Tax Rate 30.65% 19.75% 1.44% 14.14% 1.17% 0.00% 0.00% -1.03% 6.14% -0.36% 0.05% PAT 38.67 101.68 97.09 33.58 28.85 29.59 23.63 12.80 2.14 -2.77 -20.52 PAT before Minority Interest 38.67 101.68 97.09 33.58 28.84 29.77 23.63 12.80 2.14 -2.75 -20.52 Minority Interest 0.00 0.00 0.00 0.00 0.01 -0.18 0.00 0.00 0.00 -0.02 0.00 PAT Margin 2.73% 6.57% 8.17% 3.94% 3.75% 4.88% 3.97% 2.64% 0.53% -0.76% -6.30% PAT Growth -61.97% 4.73% 189.13% 16.40% -2.50% 25.22% 84.61% 498.13% - - EPS 0.76 1.99 1.90 0.66 0.56 0.58 0.46 0.25 0.04 -0.05 -0.40

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 598.17 444.97 307.25 277.46 250.56 224.34 328.85 313.08 324.26 330.42 Share Capital 95.56 89.96 89.96 89.96 89.96 89.96 209.61 209.61 209.61 209.61 Total Reserves 476.36 311.26 217.29 187.50 160.60 134.38 119.24 103.47 114.65 120.81 Non-Current Liabilities 32.41 26.89 25.36 21.11 17.87 15.28 55.22 72.69 84.05 103.36 Secured Loans 1.32 0.83 0.92 1.79 2.70 0.94 42.74 62.22 74.65 94.49 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 26.64 24.01 22.38 17.85 13.45 12.69 10.71 8.71 7.35 6.78 Current Liabilities 402.69 375.63 329.38 320.82 322.21 308.19 150.78 114.44 99.58 107.72 Trade Payables 217.32 192.33 158.38 157.08 164.89 116.20 107.48 78.55 66.75 54.90 Other Current Liabilities 159.63 163.93 157.39 153.61 156.05 190.70 39.14 32.82 30.91 52.14 Short Term Borrowings 16.13 15.32 11.36 8.99 0.00 0.00 0.00 2.23 1.19 0.00 Short Term Provisions 9.61 4.05 2.25 1.14 1.26 1.29 4.16 0.84 0.73 0.68 Total Liabilities 1,033.27 847.49 661.99 619.39 590.64 547.81 534.85 500.21 507.89 541.50 Net Block 156.11 144.02 134.84 152.59 182.10 191.29 216.36 243.93 289.47 330.91 Gross Block 479.46 516.17 641.54 777.14 890.30 922.26 914.18 907.16 902.43 898.34 Accumulated Depreciation 323.35 372.14 506.70 624.55 708.20 730.96 697.82 663.23 612.96 567.43 Non Current Assets 356.50 354.71 313.73 336.06 363.54 369.25 387.98 395.80 415.92 454.30 Capital Work in Progress 14.15 1.96 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Non Current Investment 117.79 118.78 118.78 117.69 117.69 117.69 117.69 117.94 117.94 121.81 Long Term Loans & Adv. 68.17 89.67 59.83 65.49 63.47 59.41 53.92 33.93 8.51 1.58 Other Non Current Assets 0.28 0.27 0.28 0.28 0.27 0.85 0.00 0.00 0.00 0.00 Current Assets 676.76 492.79 348.26 283.33 227.11 178.56 146.88 104.41 91.97 87.20 Current Investments 0.00 0.00 0.00 0.02 0.22 0.00 0.00 0.00 0.00 0.00 Inventories 258.25 169.61 132.47 90.84 73.94 62.50 40.82 35.36 32.91 36.75 Sundry Debtors 221.87 155.52 121.41 121.96 110.22 83.10 80.35 48.45 40.09 36.59 Cash & Bank 45.55 66.98 38.03 31.98 5.70 6.75 3.63 8.60 8.07 4.72 Other Current Assets 151.09 9.80 5.90 7.72 37.02 26.22 22.08 12.00 10.90 9.14 Short Term Loans & Adv. 146.02 90.88 50.45 30.80 31.53 21.67 16.27 8.89 7.94 6.56 Net Current Assets 274.07 117.16 18.88 -37.49 -95.10 -129.63 -3.91 -10.03 -7.61 -20.52 Total Assets 1,033.26 847.50 661.99 619.39 590.65 547.81 534.86 500.21 507.89 541.50

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 578.56 424.75 284.06 253.09 225.94 196.26 300.28 287.48 297.11 299.88 Share Capital 95.56 89.96 89.96 89.96 89.96 89.96 209.61 209.61 209.61 209.61 Total Reserves 456.75 291.04 194.10 163.13 135.98 106.30 90.67 77.87 87.50 90.27 Non-Current Liabilities 35.50 30.06 28.42 23.38 20.20 17.80 57.47 74.00 84.65 103.91 Secured Loans 1.32 0.83 0.92 1.83 2.95 1.38 43.41 62.27 74.78 94.65 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 28.24 25.39 23.82 19.01 14.42 13.59 11.34 9.22 7.82 7.17 Current Liabilities 456.46 403.80 351.44 339.17 340.12 324.86 166.56 127.92 108.14 102.73 Trade Payables 258.12 208.85 172.30 168.15 174.88 124.88 115.33 84.96 68.60 56.81 Other Current Liabilities 169.97 174.38 165.06 160.64 163.90 198.65 47.04 39.87 37.58 45.22 Short Term Borrowings 16.13 15.32 11.36 8.99 0.00 0.00 0.00 2.23 1.19 0.00 Short Term Provisions 12.24 5.25 2.72 1.39 1.33 1.33 4.19 0.86 0.77 0.70 Total Liabilities 1,070.06 858.15 663.46 615.18 585.81 538.29 523.68 489.00 489.50 506.09 Net Block 251.80 224.52 216.37 236.21 264.29 271.80 296.72 322.48 368.08 409.46 Gross Block 613.25 628.32 752.55 887.76 997.60 1,026.96 1,018.43 1,009.35 1,004.61 1,000.44 Accumulated Depreciation 361.45 403.79 536.18 651.55 733.31 755.15 721.72 686.87 636.53 590.98 Non Current Assets 335.75 331.36 291.29 315.71 342.37 346.34 366.53 374.42 393.18 415.00 Capital Work in Progress 14.15 1.96 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Non Current Investment 0.00 1.08 1.08 0.00 0.00 0.00 0.00 0.00 0.00 3.87 Long Term Loans & Adv. 69.53 103.52 73.55 79.22 77.81 73.69 69.82 51.94 25.10 1.67 Other Non Current Assets 0.28 0.27 0.28 0.28 0.27 0.85 0.00 0.00 0.00 0.00 Current Assets 734.30 526.79 372.18 299.47 243.44 191.95 157.15 114.58 96.32 91.09 Current Investments 0.00 0.00 0.00 0.02 0.22 0.00 0.00 0.00 0.00 0.00 Inventories 275.85 175.33 138.48 94.20 76.89 64.66 42.14 37.11 33.30 37.05 Sundry Debtors 250.64 181.98 137.68 133.75 121.85 92.95 87.94 56.14 42.67 39.11 Cash & Bank 45.97 67.89 38.88 32.21 5.95 7.59 4.36 8.85 9.11 5.53 Other Current Assets 161.83 10.01 5.98 7.86 38.54 26.74 22.71 12.48 11.24 9.40 Short Term Loans & Adv. 156.54 91.58 51.16 31.43 32.92 22.03 16.77 9.34 8.23 6.23 Net Current Assets 277.84 122.99 20.73 -39.70 -96.68 -132.92 -9.41 -13.34 -11.82 -11.64 Total Assets 1,070.05 858.15 663.47 615.18 585.81 538.29 523.68 489.00 489.50 506.09

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity -66.38 49.31 10.86 14.58 61.25 49.24 50.01 50.74 33.19 33.46 PBT 125.54 94.25 37.48 28.61 26.12 22.55 20.04 0.72 -9.06 -25.75 Adjustment 13.02 29.63 34.23 38.36 37.86 40.92 45.32 47.22 55.66 56.73 Changes in Working Capital -180.56 -74.56 -55.33 -52.40 -2.72 -14.23 -11.09 2.94 -16.31 -0.60 Cash after chg. in Working capital -41.99 49.31 16.38 14.58 61.25 49.24 54.27 50.88 30.29 30.38 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -24.39 0.00 -5.52 0.00 0.00 0.00 0.14 -0.14 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 -4.40 0.00 2.90 3.08 Cash From Investing Activity -22.64 -69.09 -12.08 -10.34 -24.28 -14.67 -27.08 -30.22 -0.65 -2.51 Net Fixed Assets 24.52 123.41 135.60 113.16 31.96 -8.08 -7.02 -4.73 -4.09 -2.87 Net Investments 0.99 0.00 -1.07 0.20 -0.22 0.00 0.25 0.00 3.87 0.00 Others -48.15 -192.50 -146.61 -123.70 -56.02 -6.59 -20.31 -25.49 -0.43 0.36 Cash from Financing Activity 63.93 47.46 4.65 -0.35 -37.67 -31.29 -27.89 -19.99 -29.19 -30.19 Net Cash Inflow / Outflow -25.09 27.68 3.43 3.89 -0.69 3.29 -4.97 0.53 3.35 0.76 Opening Cash & Equivalents 40.47 12.79 9.36 5.47 6.16 2.87 8.60 8.07 4.72 3.96 Closing Cash & Equivalent 15.38 40.47 12.79 9.36 5.47 6.16 3.63 8.60 8.07 4.72

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity -57.76 50.83 11.02 17.37 63.41 40.73 50.07 50.70 33.52 33.64 PBT 126.70 98.51 39.11 29.18 29.77 23.04 17.06 2.28 -5.64 -23.60 Adjustment 19.46 31.96 36.63 40.32 38.64 41.40 45.69 47.32 55.76 56.80 Changes in Working Capital -178.99 -78.18 -58.84 -51.78 -5.00 -23.72 -8.41 1.23 -19.50 -2.64 Cash after chg. in Working capital -32.83 52.29 16.89 17.71 63.41 40.73 54.34 50.83 30.62 30.56 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -24.93 -1.46 -5.88 -0.34 0.00 0.00 0.13 -0.13 0.01 0.01 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 -4.40 0.00 0.00 0.00 Cash From Investing Activity -31.68 -70.35 -12.46 -13.05 -26.93 -13.60 -27.30 -31.65 -0.80 -2.83 Net Fixed Assets 24.52 123.41 135.60 113.16 31.96 -8.08 -7.02 -4.73 -4.09 -2.87 Net Investments 0.99 0.00 -1.07 0.20 -0.22 0.00 0.25 0.00 3.87 0.00 Others -57.19 -193.76 -146.99 -126.41 -58.67 -5.52 -20.53 -26.92 -0.58 0.04 Cash from Financing Activity 63.85 47.27 5.49 -0.44 -37.77 -23.72 -27.26 -19.31 -29.14 -29.79 Net Cash Inflow / Outflow -25.58 27.75 4.04 3.88 -1.29 3.40 -4.49 -0.26 3.58 1.02 Opening Cash & Equivalents 41.39 13.64 9.60 5.72 7.00 3.60 8.85 9.11 5.53 4.51 Closing Cash & Equivalent 15.80 41.39 13.64 9.60 5.72 7.00 4.36 8.85 9.11 5.53

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 11.97 8.92 6.83 6.17 5.57 4.99 4.65 4.30 4.55 4.69 ROA 10.75% 12.49% 5.05% 4.73% 4.59% 4.28% 3.05% 0.12% -1.17% -4.03% ROE 20.77% 26.61% 11.06% 10.84% 11.00% 10.69% 7.84% 0.29% -2.97% -10.21% ROCE 23.73% 24.54% 10.82% 7.74% 9.26% 9.17% 6.60% 2.32% 0.87% -2.42% Fixed Asset Turnover 2.91 1.92 1.12 0.86 0.62 0.60 0.51 0.42 0.38 0.34 Receivable days 47.52 45.43 56.08 59.08 62.91 54.48 50.93 42.76 41.07 41.14 Inventory Days 53.88 49.56 51.46 41.93 44.40 34.44 30.13 32.97 37.31 44.11 Payable days 81.12 92.58 79.07 88.97 104.24 84.35 83.75 77.64 70.84 71.22 Cash Conversion Cycle 20.28 2.41 28.47 12.04 3.07 4.58 -2.69 -1.90 7.54 14.02 Total Debt/Equity 0.03 0.04 0.04 0.47 0.53 0.22 0.20 0.26 0.27 0.34 Interest Cover 52.75 53.71 20.05 14.82 7.08 4.10 2.50 1.08 0.38 -0.95

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 11.56 8.47 6.32 5.63 5.02 4.36 4.02 3.73 3.95 4.01 ROA 10.55% 12.76% 5.25% 4.80% 5.30% 4.45% 2.53% 0.44% -0.55% -3.90% ROE 21.79% 29.20% 12.50% 12.04% 14.10% 12.54% 7.35% 1.24% -1.54% -10.77% ROCE 24.86% 27.13% 12.05% 10.01% 14.05% 10.18% 6.29% 2.90% 1.80% -2.09% Fixed Asset Turnover 2.49 1.72 1.04 0.82 0.60 0.58 0.49 0.41 0.37 0.33 Receivable days 51.04 49.10 58.07 60.70 64.63 55.44 53.22 44.17 40.16 40.83 Inventory Days 53.23 48.20 49.78 40.63 42.59 32.73 29.27 31.48 34.55 41.63 Payable days 86.93 94.60 79.06 88.85 103.38 82.97 83.88 76.01 67.69 69.30 Cash Conversion Cycle 17.35 2.71 28.78 12.48 3.85 5.20 -1.39 -0.36 7.02 13.16 Total Debt/Equity 0.03 0.04 0.05 0.52 0.06 0.25 0.22 0.28 0.30 0.37 Interest Cover 53.22 56.09 20.71 14.83 7.83 4.13 2.21 1.26 0.72 -0.77

Top Investors:

pinfold overseas limited

damodar prasad agarwal

morepen laboratories limited

Annual Reports:

News Update:

USFDA conducts inspection of Morepen Laboratories’ API manufacturing facility at Baddi
27th Mar 2023, 14:08 PM

The facility has been cleared by USFDA on March 24, 2023 without any adverse observation
Read More
Morepen Laboratories incorporates wholly owned subsidiary
18th Mar 2023, 11:05 AM

The company has incorporated a WOS on March 17, 2023
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback